Yonekawa W D, Kupferberg H J, Woodbury D M
J Pharmacol Exp Ther. 1980 Sep;214(3):589-93.
Pentylenetetrazol (PTZ) is often used in experimental models of epilepsy. The relationship of the PTZ-induced seizure sequence of myoclonus, clonus and hindlimb extension (TE) to brain PTZ levels has not been reported. This study examined this relationship and determined how different routes of PTZ administration affected brain PTZ uptake and seizure development. The critical brain PTZ level for onset of clonus ranged from 20 to 50 microg/g. Brain PTZ uptake was rapid after I.P. injection of PTZ convulsant dose (CD55) for clonus/and clonus onset occured at 4.0+/- 1.6 min. uptake was slower after S.C. administration; clonus onset occurred at 9.9 +/- 3.7 min. at a CD for TE (CD40), clonus onset occured at 5.1 +/- 3.0 and 2.4 +/- 2.4 min for S.C. and I.P. routes of administration, respectively. TE onset did not appear to depend solely on brain PTZ levels were falling . Factors that could modulate the appearance of TE are discussed.
戊四氮(PTZ)常用于癫痫实验模型。PTZ诱导的肌阵挛、阵挛和后肢伸展(TE)癫痫发作序列与脑内PTZ水平的关系尚未见报道。本研究考察了这种关系,并确定了不同的PTZ给药途径如何影响脑内PTZ摄取和癫痫发作发展。阵挛发作的关键脑内PTZ水平为20至50微克/克。腹腔注射PTZ惊厥剂量(CD55)后,脑内PTZ摄取迅速,阵挛发作在4.0±1.6分钟出现;皮下给药后脑内PTZ摄取较慢,阵挛发作在9.9±3.7分钟出现。对于TE的惊厥剂量(CD40),皮下和腹腔给药途径的阵挛发作分别在5.1±3.0分钟和2.4±2.4分钟出现。TE发作似乎并不完全取决于脑内PTZ水平的下降。文中讨论了可能调节TE出现的因素。